<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Myeloid <z:hpo ids='HP_0100242'>sarcoma</z:hpo> (MS) is a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> mass of myeloblasts or immature myeloid cells occurring in an extramedullary site or in bone </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> mass may precede or occur concurrently with <z:hpo ids='HP_0011009'>acute</z:hpo> or <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> or with other types of <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> or <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>MS is a <z:e sem="disease" ids="C0678236" disease_type="Disease or Syndrome" abbrv="">rare disease</z:e>, estimated to comprise between 2 to approximately 14% of <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>On the other hand, 95% of cases of <z:mp ids='MP_0005481'>CML</z:mp> have characteristic t (9;22) cytogenetic abnormality and BCR/ABL fusion gene at diagnosis </plain></SENT>
<SENT sid="4" pm="."><plain>We here report the clinical significance of FISH in a diagnosis of MS that formed <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> in femur during the <z:hpo ids='HP_0011010'>chronic</z:hpo> phase of <z:mp ids='MP_0005481'>CML</z:mp> </plain></SENT>
</text></document>